MicroRNA 6842 (MIR6842)

MicroRNA 6842 (MIR6842) is a short non-coding RNA (~20-24 nucleotides) expressed in humans and is part of the microRNA gene class[1]. Like other miRNAs, it likely regulates gene expression post-transcriptionally by binding to target messenger RNA (mRNA) transcripts, primarily resulting in mRNA destabilization or translational repression via its incorporation into the RNA-induced silencing complex (RISC)[1][4][5]. The mature form of MIR6842 is generated through a multi-step biosynthesis process that includes transcription, precursor processing by Drosha and Dicer enzymes, and association with Argonaute proteins[1][4]. MIR6842 is reported to have an association with diffuse pulmonary fibrosis, though there are no detailed mechanistic studies or validated clinical roles currently published[1]. There are no documented direct drug interactions, biomarkers, or safety concerns related to MIR6842. As for its biological function, it likely participates in the broader regulatory activities attributable to microRNAs, including influencing processes such as cell proliferation, differentiation, and apoptosis in a context-dependent manner[1][2][5]. Due to limited specific information available for MIR6842, most functional and disease associations remain inferred from general miRNA properties, not unique to this particular microRNA. If you need structured data or more information on miRNAs in disease or as therapeutic targets in general, such as mechanisms, drug interactions, or safety profile, this would require broader inquiry into microRNA-targeting therapeutics. MIR6842 itself currently lacks the data for such applications[1][5].

Other names

hsa-mir-6842microRNA mir-6842MIR6842